HTA78 Evaluations of Cost-Utility Analyses of Pharmaceuticals Receiving Market Authorization Based on Single-Arm Trials in the Netherlands
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1538
https://www.valueinhealthjournal.com/article/S1098-3015(22)03743-3/fulltext
Title :
HTA78 Evaluations of Cost-Utility Analyses of Pharmaceuticals Receiving Market Authorization Based on Single-Arm Trials in the Netherlands
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03743-3&doi=10.1016/j.jval.2022.09.1538
First page :
Section Title :
Open access? :
No
Section Order :
11089